| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | SB-225002 | CTRPv2 | pan-cancer | AAC | 0.05 | 0.1 |
| mRNA | VX-680 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.1 |
| mRNA | BRD-K27224038 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.1 |
| mRNA | Parthenolide | GDSC1000 | pan-cancer | AAC | 0.083 | 0.1 |
| mRNA | ELCPK | CTRPv2 | pan-cancer | AAC | 0.081 | 0.1 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.079 | 0.1 |
| mRNA | valdecoxib | CTRPv2 | pan-cancer | AAC | 0.056 | 0.1 |
| mRNA | lenvatinib | CTRPv2 | pan-cancer | AAC | 0.058 | 0.1 |
| mRNA | Nutlin-3 | CTRPv2 | pan-cancer | AAC | 0.054 | 0.1 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | -0.054 | 0.1 |